Cognizant Technology Solutions (CTSH) Tops Q3 EPS by 10c; Issues Mixed Q4, FY12 Outlook
Get Alerts CTSH Hot Sheet
Price: $41.83 --0%
EPS Growth %: +5.3%
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +5.3%
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Cognizant Technology Solutions (NASDAQ: CTSH) reported Q3 EPS of $0.97, $0.10 better than the analyst estimate of $0.87. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.88 billion.
Cognizant Technology Solutions sees FY2012 EPS of $3.69, versus the consensus of $3.39. Cognizant Technology Solutions sees FY2012 revenue of $7.34 billion, versus the consensus of $7.34 billion.
Cognizant Technology Solutions sees Q4 2012 EPS of $0.97, versus the consensus of $0.91. Cognizant Technology Solutions sees Q4 2012 revenue of $1.94 billion, versus the consensus of $1.96 billion.
For earnings history and earnings-related data on Cognizant Technology Solutions (CTSH) click here.
Cognizant Technology Solutions sees FY2012 EPS of $3.69, versus the consensus of $3.39. Cognizant Technology Solutions sees FY2012 revenue of $7.34 billion, versus the consensus of $7.34 billion.
Cognizant Technology Solutions sees Q4 2012 EPS of $0.97, versus the consensus of $0.91. Cognizant Technology Solutions sees Q4 2012 revenue of $1.94 billion, versus the consensus of $1.96 billion.
For earnings history and earnings-related data on Cognizant Technology Solutions (CTSH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share